Tab Application Banner
  • Users Online: 802
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
Year : 2012  |  Volume : 7  |  Issue : 4  |  Page : 221-225

Newer glucocorticoids: Overcoming mechanistic hurdles

Department of Rheumatology, MES Medical College, Perinthalmanna 679338, Kerala, India

Correspondence Address:
Vinod Ravindran
Department of Rheumatology, MES Medical College, Perinthalmanna 679338, Kerala
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.1016/j.injr.2012.10.001

Rights and Permissions

Glucocorticoids (GCs) are used in the management of inflammatory disorders such as allergies, asthma, sepsis and several autoimmune diseases including of skin, bowel and joints. Recently the concerns regarding the safety of GCs have resulted in their renewed appraisal. Recognition of GC resistance has also contributed to the drive of the development of new technologies to utilise the GCs better. Use of the knowledge about mechanisms of action of GCs to overcome the undesirable effects has resulted in newer GC molecules, novel drug delivery systems and novel drug combinations which hold promise for the optimum use of GCs in future.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded141    
    Comments [Add]    
    Cited by others 3    

Recommend this journal